The FDA has issued a recall for certain eye drops after receiving a consumer complaint.


December 26, 2024 Tags:

Systane Lubricant Eye Drops have been voluntarily recalled following a discovery of possible fungal contamination, the U.S. Food and Drug Administration (FDA) announced. The recall affects one batch of the product, specifically the Systane Lubricant Eye Drops Ultra PF, which were sold in single-use vials. The decision to recall the product was prompted by a consumer complaint about foreign material found inside one of the sealed vials.
The FDA's investigation revealed that the foreign material in question was fungal in nature, leading to the decision to pull the affected lot from the market. This fungal contamination presents a serious risk to users, especially those with weakened immune systems. If the contaminated drops are used, they could potentially cause eye infections that might result in vision loss or, in very rare cases, even be life-threatening for individuals with compromised immune systems.

Alcon Laboratories, the company responsible for manufacturing the Systane eye drops, has emphasized that there have been no reports of adverse effects or illnesses linked to the product thus far. The company reassured the public that the contamination appeared to be isolated to the single vial returned by a customer, and the recall was issued as a precautionary measure to prioritize the safety of consumers.

The affected batch of Systane eye drops comes in a 25-count package of on-the-go single-use vials. These vials have a lot number of 10101 and an expiration date of September 2025. The product was sold primarily at Publix grocery stores, which has issued a notice about the recall.

Systane eye drops are commonly used to treat dryness and irritation in the eyes, providing relief from the burning and discomfort that often accompanies dry eye symptoms. They are typically sold in small, portable vials for convenience, especially for people who need to manage their dry eye condition while on the go.

Consumers who have purchased the recalled product are urged to stop using it immediately. They can return the product to the place of purchase for a refund or replacement. The FDA also advises that anyone who has used the recalled eye drops and is experiencing symptoms, such as eye discomfort or irritation, should seek medical attention from a healthcare provider promptly.

Alcon, in response to the recall, assured that it is conducting an ongoing investigation to understand the root cause of the contamination. However, they stated that the foreign material seems to be limited to the single unit that was returned. As a result, the company took the necessary step to recall the affected batch out of an abundance of caution, ensuring that the safety and well-being of consumers remain a top priority.

The recall of Systane eye drops highlights the importance of vigilance when it comes to product safety, particularly for items that come in direct contact with sensitive areas like the eyes. While the recall seems to be isolated to a specific lot, it serves as a reminder to consumers to always check product labels and lot numbers, especially in the case of medical products.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Doctors Concerned Iodine Deficiency Is Resurfacing Again

A 13-year-old boy came to a clinic with a rapidly swelling neck, leaving doctors initially puzzled. Tests ruled out their....

China Hits New Virus Outbreak, 5 Years After Covid Crisis

China is currently grappling with an outbreak of the Human Metapneumovirus (HMPV), which is spreading rapidly across the country. This....

B.C. Teen Beats Avian Flu, Off Oxygen and Recovered: Report

A 13-year-old girl from British Columbia, who was the first reported human case of H5N1 avian flu in Canada, is....

Norovirus Strikes Back: US Cases Surge as Stomach Virus Rises

Norovirus outbreaks are on the rise in various regions across the United States this winter, according to recent reports from....

Whooping Cough Spikes in Canada: Outbreaks Across Provinces

Canada is witnessing a concerning rise in whooping cough (pertussis) cases this year, with health officials reporting higher-than-normal numbers across....

Dr. Tam Highlights Health Risks for Canada in 2025

As Canada heads into 2025, Dr. Theresa Tam, the country's chief public health officer, has highlighted some of the biggest....

Ontario Faces Surge in Measles Cases: 37 Confirmed in Latest Outbreak

Ontario is witnessing a concerning surge in measles cases, with 37 individuals now confirmed to be infected. This outbreak, which....

Oysters in B.C., Alberta, and Ontario Recalled Over Norovirus Risk

The Canadian Food Inspection Agency (CFIA) has announced the recall of certain oysters distributed in British Columbia, Alberta, and Ontario....

Measles Alert: AHS Confirms Case in Calgary, Issues Warning

Alberta Health Services (AHS) has issued a public advisory after confirming that an individual with measles visited multiple public locations....

California Issues State of Emergency for H5N1 Bird Flu

The U.S. has reported its first severe human case of bird flu, with a Louisiana resident currently in critical condition,....

Prenatal Test Reveals Hidden Cancer: What Doctors Should Watch For

Dr. Naseem Khorram, a Los Angeles nephrologist, was going through routine prenatal testing during her second pregnancy when something unexpected....

Health Stories to Watch in 2025: Bird Flu, Toxic Drugs, and More

In 2025, health experts are closely following several important stories that could shape our healthcare landscape. From the rising threat....